Singapore markets closed

Iterum Therapeutics plc (ITRM)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.5500-0.0200 (-1.27%)
At close: 04:00PM EDT
1.5700 +0.02 (+1.29%)
After hours: 04:08PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
15,479
39,992
17,617
10,712
21,074
Selling general and administrative
13,807
7,476
12,766
13,825
11,052
Total operating expenses
29,286
47,468
30,383
24,537
32,126
Operating income or loss
-29,286
-47,468
-30,383
-24,537
-32,126
Interest expense
3,213
1,428
2,361
5,553
15,097
Total other income/expenses net
-10,656
11,138
-11,389
-60,769
-1,192
Income before tax
-43,155
-37,758
-44,133
-90,859
-51,263
Income tax expense
371
613
301
705
743
Income from continuing operations
-43,526
-38,371
-44,434
-91,564
-52,006
Net income
-43,526
-38,371
-44,434
-91,564
-52,006
Net income available to common shareholders
-43,526
-38,371
-44,434
-91,564
-52,006
Basic EPS
-2.43
-
-3.63
-8.41
-32.49
Diluted EPS
-2.43
-
-3.63
-8.41
-32.49
Basic average shares
12,740
-
12,237
10,891
1,601
Diluted average shares
12,740
-
12,237
10,891
1,601